Trader Note — 9846 total
PAG enters the week after its Q1 earnings print with a notable shift in analyst sentiment — multiple firms have raised price targets in the wake of results, even as the stock pulled back 2.4% on Tuesday. The clearest…
FXR — the First Trust Industrials/Producer Durables AlphaDEX ETF — heads into mid-May with its most striking data point being a dramatic unwind of short positioning that built aggressively through mid-April. The short…
SMCI enters the week after earnings in a position that would have seemed improbable a month ago: the stock is up 18% on the week and 30% over the past month, the short base is shrinking at pace, and the options market…
Volkswagen AG heads into the week with a headline that cuts across the grain of its own cost-cutting narrative: Chinese EV maker Xpeng is reportedly exploring a deal to acquire a Volkswagen factory in Europe. The…
Celsius Holdings heads into its May 28 earnings print with short sellers aggressively rebuilding positions while the options market tells the opposite story — a rare and charged divergence for a stock already down 15%…
Western Union enters mid-May with short sellers at their most aggressive in months — even as the stock sits at a level where the math barely makes sense. Short interest has climbed sharply. The SI % of free float…
Cytosorbents Corporation filed its Q1 2026 results today — and the stock's 7% single-day drop tells most of the story before you even open the release. Revenue of $8.86 million missed the consensus estimate of $9.36…
Chipotle Mexican Grill heads into the week after its April earnings with a striking divergence: shorts have rebuilt sharply even as analysts largely affirmed their bullish stance post-results. Short interest is the…
The Hanover Insurance Group heads into the week after its Q1 earnings with a clear narrative: a solid beat has prompted a wave of analyst target upgrades, while short sellers have quietly trimmed their positions in…
Can-Fite BioPharma heads into the week with short sellers in full retreat — a dramatic reversal from a peak that coincided almost exactly with its most important clinical readout in years. The positioning story over…
AT&T walks into its Q1 2026 earnings print tomorrow — Wednesday, May 14 — having shed 5% over the past month to $25.23, down nearly 3% on the week even after a modest bounce on Tuesday. The backdrop is one of quiet…
Inovio Pharmaceuticals has surged 24% in a week to $1.41, but its short sellers are not backing down — and the gap between those two signals makes this week's setup genuinely uncomfortable. Short interest has climbed…
PBH heads into tomorrow's Q4 earnings with a sharply contradictory setup: insiders dumped shares at the top of the week, short sellers piled in at a one-month record pace, yet options traders are leaning bullish. The…
TEF reports Q1 2026 results on May 14 with short sellers pulling back from their peak positions, borrow costs creeping higher over the month, and analysts sitting modestly above where the stock trades now. The most…
NUAG has put up one of the more eye-catching moves in the silver space this week — but insider selling through the run-up raises a question worth sitting with. The stock climbed 13% over the past five sessions to CAD…
Dyadic International closed out the week on the back foot — the stock down 6.1% on the week to $0.7228 — but the more interesting development is in the lending market, where short sellers have been cutting exposure at…
ISCG — the iShares Morningstar Small-Cap Growth ETF — enters the back half of May with short interest doubling in a month and the borrow market tightening alongside it, a notable shift in positioning against a…
OptimumBank Holdings heads into its Q1 2026 earnings tomorrow with the most bullish analyst setup it has seen in months — and the short side looking increasingly thin. The standout this week is the timing of the…
Marchex heads into the post-earnings session with a Q1 miss on both revenue and earnings, but a $10 million strategic funding deal with Archenia adds a complicating wrinkle to what would otherwise be a clean bearish…
Arrowhead Pharmaceuticals heads into mid-May with a striking divergence: the Street is growing more constructive, yet short sellers are rebuilding positions at their fastest weekly pace in over a month. Short interest…
